• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

地塞米松植入术后并发症的外科治疗

Surgical Management of Complications after Dexamethasone Implant.

作者信息

Sborgia Giancarlo, Niro Alfredo, D'Oria Francesco, Galeone Alessandra, Sborgia Luigi, Boscia Francesco, Sborgia Alessandra, Alessio Giovanni

机构信息

Department of Medical Science, Neuroscience and Sense Organs, Eye Clinic, University of Bari, Bari, Italy.

Eye Clinic, Hospital "S. G. MOSCATI, " ASL TA, Taranto, Italy.

出版信息

Case Rep Ophthalmol Med. 2020 Feb 10;2020:4837689. doi: 10.1155/2020/4837689. eCollection 2020.

DOI:10.1155/2020/4837689
PMID:32095301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7035535/
Abstract

PURPOSE

To report surgical management of ocular complications occurred after dexamethasone (DEX) implant (Ozurdex®) injection.

METHODS

Retrospective interventional case series.

RESULTS

Different surgical procedures including viscoexpression to manage the migration of the implant into the anterior chamber, "phaco-rolling" technique for the intralenticular injection, and vitrectomy with implant removal for an acute endophthalmitis were performed. Successful management of different complications after DEX implant by using individualized surgical approaches was observed.

CONCLUSIONS

Early and targeted surgical management is required in selected cases of ocular complications after DEX implant. The implant removal was needed to preserve ocular anatomy and function.

摘要

目的

报告地塞米松（DEX）植入物（Ozurdex®）注射后发生的眼部并发症的手术治疗。

方法

回顾性介入病例系列。

结果

实施了不同的手术操作，包括用于处理植入物向前房迁移的粘弹剂注入、用于晶状体囊内注射的“超声乳化滚动”技术，以及用于急性眼内炎的玻璃体切割联合植入物取出术。观察到通过采用个体化手术方法成功处理了DEX植入后的不同并发症。

结论

对于DEX植入后发生眼部并发症的特定病例，需要早期且有针对性的手术治疗。为了保留眼部结构和功能，需要取出植入物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b9e/7035535/39663d3b0973/CRIOPM2020-4837689.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b9e/7035535/9d3542e6c33d/CRIOPM2020-4837689.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b9e/7035535/39663d3b0973/CRIOPM2020-4837689.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b9e/7035535/9d3542e6c33d/CRIOPM2020-4837689.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b9e/7035535/39663d3b0973/CRIOPM2020-4837689.002.jpg

相似文献

1
Surgical Management of Complications after Dexamethasone Implant.地塞米松植入术后并发症的外科治疗
Case Rep Ophthalmol Med. 2020 Feb 10;2020:4837689. doi: 10.1155/2020/4837689. eCollection 2020.
2
Dexamethasone implant anterior chamber migration: risk factors, complications, and management strategies.地塞米松植入前房内迁移：危险因素、并发症和管理策略。
Ophthalmology. 2014 Jan;121(1):67-71. doi: 10.1016/j.ophtha.2013.06.033. Epub 2013 Jul 24.
3
The clinical outcomes of surgical management of anterior chamber migration of a dexamethasone implant (Ozurdex®).地塞米松植入物（Ozurdex®）前房移位的手术治疗临床结果
Graefes Arch Clin Exp Ophthalmol. 2017 Sep;255(9):1819-1825. doi: 10.1007/s00417-017-3705-y. Epub 2017 Jun 10.
4
Management and Complications of Dexamethasone Intravitreal Implant Migration Into the Anterior Chamber.地塞米松玻璃体内植入物迁移至前房的管理与并发症
J Vitreoretin Dis. 2022 Dec 7;6(6):432-436. doi: 10.1177/24741264221138166. eCollection 2022 Nov-Dec.
5
CASE REPORT OF ABIOTROPHIA DEFECTIVA ENDOPHTHALMITIS AFTER REPEATED INJECTIONS OF DEXAMETHASONE INTRAVITREAL IMPLANT (OZURDEX).曲安奈德眼内植入剂（欧适维）重复注射后引起的败血性眼内炎病例报告
Retin Cases Brief Rep. 2022 Mar 1;16(2):170-173. doi: 10.1097/ICB.0000000000000925.
6
Anterior segment migration of dexamethasone implant: risk factors, complications, and management.地塞米松植入物的前段移位：危险因素、并发症及处理
Curr Opin Ophthalmol. 2017 May;28(3):246-251. doi: 10.1097/ICU.0000000000000365.
7
Management of anterior chamber dislocation of dexamethasone implant.地塞米松植入物前房脱位的处理。
Ocul Immunol Inflamm. 2013;21(1):90-1. doi: 10.3109/09273948.2012.736589.
8
Surgical removal of inadvertent intralenticular sustained-release dexamethasone implant (ozurdex) and implant one-piece posterior capsule intraocular lens.手术取出意外进入晶状体的缓释地塞米松植入物（Ozurdex）并植入一体式后囊人工晶状体。
Saudi J Ophthalmol. 2020 Dec 28;34(2):145-147. doi: 10.4103/1319-4534.305044. eCollection 2020 Apr-Jun.
9
Active removal of anterior segment-migrated dexamethasone implant (Ozurdex).主动移除前段移位的地塞米松植入物（Ozurdex）。
GMS Ophthalmol Cases. 2022 Mar 22;12:Doc08. doi: 10.3205/oc000195. eCollection 2022.
10
Management of anterior chamber dislocation of a dexamethasone intravitreal implant: a case report.地塞米松玻璃体内植入物前房脱位的处理：一例报告
J Med Case Rep. 2016 Oct 13;10(1):282. doi: 10.1186/s13256-016-1077-2.

引用本文的文献

1
Anterior Segment Optical Coherence Tomography Evaluation of a Dexamethasone Intravitreal Implant in the Crystalline Lens: A Case Report.晶体状体内地塞米松玻璃体内植入物的眼前节光学相干断层扫描评估：病例报告
Int Med Case Rep J. 2025 Jan 7;18:27-32. doi: 10.2147/IMCRJ.S486866. eCollection 2025.
2
Management and Complications of Dexamethasone Intravitreal Implant Migration Into the Anterior Chamber.地塞米松玻璃体内植入物迁移至前房的管理与并发症
J Vitreoretin Dis. 2022 Dec 7;6(6):432-436. doi: 10.1177/24741264221138166. eCollection 2022 Nov-Dec.
3
Mid-term safety and effectiveness of intravitreal dexamethasone implant to treat persistent cystoid macular edema in vitrectomized eyes for bacterial endophthalmitis.

本文引用的文献

1
INTRAVITREAL DEXAMETHASONE IMPLANT MIGRATION INTO THE ANTERIOR CHAMBER: A Multicenter Study From the Pan-American Collaborative Retina Study Group.玻璃体内曲安奈德植入物迁移至前房：泛美合作视网膜研究组的一项多中心研究。
Retina. 2020 May;40(5):825-832. doi: 10.1097/IAE.0000000000002475.
2
Complications of Intravitreous Injections in Patients with Diabetes.糖尿病患者玻璃体内注射的并发症
Semin Ophthalmol. 2018;33(1):42-50. doi: 10.1080/08820538.2017.1353811.
3
The clinical outcomes of surgical management of anterior chamber migration of a dexamethasone implant (Ozurdex®).
玻璃体切除术后细菌眼内炎患眼持续性囊样黄斑水肿应用玻璃体内注射地塞米松植入物的中期安全性和有效性。
Graefes Arch Clin Exp Ophthalmol. 2022 Aug;260(8):2703-2710. doi: 10.1007/s00417-022-05615-8. Epub 2022 Mar 7.
4
Pharmacokinetics of Pullulan-Dexamethasone Conjugates in Retinal Drug Delivery.普鲁兰多糖-地塞米松缀合物在视网膜药物递送中的药代动力学
Pharmaceutics. 2021 Dec 21;14(1):12. doi: 10.3390/pharmaceutics14010012.
地塞米松植入物（Ozurdex®）前房移位的手术治疗临床结果
Graefes Arch Clin Exp Ophthalmol. 2017 Sep;255(9):1819-1825. doi: 10.1007/s00417-017-3705-y. Epub 2017 Jun 10.
4
No-Touch Removal of Anterior Segment-Migrated Dexamethasone Implant.前段迁移地塞米松植入物的非接触式取出
Retina. 2015 Nov;35(11):2414-6. doi: 10.1097/IAE.0000000000000753.
5
The Association between Intravitreal Steroids and Post-Injection Endophthalmitis Rates.玻璃体内注射类固醇与注射后眼内炎发生率之间的关联。
Ophthalmology. 2015 Nov;122(11):2311-2315.e1. doi: 10.1016/j.ophtha.2015.07.005. Epub 2015 Aug 15.
6
Pars Plana Vitrectomy With or Without Silicone Oil Endotamponade in Surgical Management of Endophthalmitis.玻璃体切割术联合或不联合硅油眼内填充在眼内炎手术治疗中的应用
Asia Pac J Ophthalmol (Phila). 2012 Jul-Aug;1(4):216-21. doi: 10.1097/APO.0b013e31826000cd.
7
Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema.为期三年的随机、假手术对照试验：地塞米松眼内植入物治疗糖尿病性黄斑水肿患者。
Ophthalmology. 2014 Oct;121(10):1904-14. doi: 10.1016/j.ophtha.2014.04.024. Epub 2014 Jun 4.
8
Desegmentation of Ozurdex implant in vitreous cavity: report of two cases.玻璃体内分解 Ozurdex 植入物：两例报告。
Br J Ophthalmol. 2014 Jul;98(7):961-3. doi: 10.1136/bjophthalmol-2014-304866. Epub 2014 Mar 19.
9
Accidental injections of dexamethasone intravitreal implant (Ozurdex) into the crystalline lens.地塞米松玻璃体内植入剂（Ozurdex）意外注射入晶状体。
Eur J Ophthalmol. 2014 Jul-Aug;24(4):633-6. doi: 10.5301/ejo.5000439. Epub 2014 Feb 25.
10
Risk factors for acute endophthalmitis following cataract surgery: a systematic review and meta-analysis.白内障手术后急性眼内炎的危险因素：系统评价和荟萃分析。
PLoS One. 2013 Aug 26;8(8):e71731. doi: 10.1371/journal.pone.0071731. eCollection 2013.